NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX), a leading provider of biotechnology-based products and services across pharmaceutical, academic, diagnostic, life science and industrial markets, today reported financial results for the quarter ended September 30, 2009. Revenues for the quarter were $7.2 million, compared to $6.9 million for the same period in 2008. Revenues for the third quarter of 2009 were positively impacted by a 29% increase in revenues from Life Science products compared to the third quarter of 2008.
